<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-TOC42LUW/390bfbae-c8ae-4a01-8c67-e07398e66c1f/HTML"><dcterms:extent>26 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-TOC42LUW/63595d79-9b1e-4439-a466-5b3e706836fd/PDF"><dcterms:extent>66 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-TOC42LUW/a2d0fdf9-a3b4-4ef7-8e2a-f6b778cd752d/TEXT"><dcterms:extent>19 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-TOC42LUW"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2004</dcterms:issued><dc:creator>Globočnik Petrovič, Mojca</dc:creator><dc:creator>Lumi, Xhevat</dc:creator><dc:format xml:lang="sl">številka:5</dc:format><dc:format xml:lang="sl">letnik:73</dc:format><dc:format xml:lang="sl">str. 389-392</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:17927641</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-TOC42LUW</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">Amfotericin B</dc:subject><dc:subject xml:lang="en">Amphotericin B</dc:subject><dc:subject xml:lang="en">Drug Therapy</dc:subject><dc:subject xml:lang="en">Endoftalmitis</dc:subject><dc:subject xml:lang="en">Endophthalmitis</dc:subject><dc:subject xml:lang="en">Eye Infections, Fungal</dc:subject><dc:subject xml:lang="en">Fluconazole</dc:subject><dc:subject xml:lang="sl">Flukonazol</dc:subject><dc:subject xml:lang="sl">mikoze</dc:subject><dc:subject xml:lang="sl">očesne bolezni</dc:subject><dc:subject xml:lang="sl">Očesne infekcije glivične</dc:subject><dc:subject xml:lang="en">Surgery</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="en">Treatment Outcome</dc:subject><dc:subject xml:lang="en">Vitrectomy</dc:subject><dc:subject xml:lang="sl">Vitrektomija</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dc:subject xml:lang="sl">Zdravljenje, izid</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Zdravljenje endogenega glivičnega endoftalmitisa| Treatment of endogenous fungal endophthalmitis|</dc:title><dc:description xml:lang="sl">Background. To report clinical findings and treatment possibilities of patients with endogenous fungal endophthalmitis. Methods. Records of patients with endogenous fungal endophthalmitis treated at Eye Clinic from January 2000to July 2003 were retrospectively reviewed. Information obtained from the medical record include the patient age, sex, causative organism, ocular treatment, systemic antifungal treatment, complications, length of follow-up and final visual outcome. Results. 12 patients (13 eyes) were enrolled (9 males, 3 females, age 18 to 35). Clinical signs of infection cleared and visual acuity improved in all 13 eyes. Conclusions. Pars plana vitrectomy in combination with intravitreal injection of amphotericin B and oral fluconazoleis an effective alternative in managament of endogenous fungal endophthalmitis in selected cases</dc:description><dc:description xml:lang="sl">Izhodišča. Poročati o kliničnih znakih in možnostih zdravljenja bolnikov z endogenim glivičnim endoftalmitisom. Metode. Retrospektivno smo pregledali dokumentacijo bolnikov z endogenim glivičnim endoftalmitisom, ki so se zdravili na Očesni kliniki v času od januarja 2001 do julija 2003. Analiziralismo naslednje podatke: starost, spol, povzročitelje, očesno zdravljenje, sistemsko antiglivično zdravljenje, zaplete, obdobje spremljanja po zdravljenju ter vidno funkcijo po končanem zdravljenju. Rezultati. V študijo je bilo vključenih 12 bolnikov (13 oči): 3 ženske, 9 moških, v starosti med 18 in 35 let. Po končanem zdravljenju je pri vseh bolnikih prišlodo ozdravljenja vnetja ter izboljšanja vidne funkcije. Zaključki. Vitrektomija pars plana v kombinaciji z intravitrealnim vnosom amfotericina B ob peroralnem jemanju flukonazola je učinkovito zdravljenje endogenega glivičnega endoftalmitisa v izbranih primerih</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-TOC42LUW"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-TOC42LUW" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-TOC42LUW/63595d79-9b1e-4439-a466-5b3e706836fd/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-TOC42LUW/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-TOC42LUW" /></ore:Aggregation></rdf:RDF>